From: ExaCT: automatic extraction of clinical trial characteristics from journal publications
Information element | at least one relevant answer per article | all answers | ||||
---|---|---|---|---|---|---|
 | # of articles with expert's answers | system's suggestion | top5 recall | # of sentences with expert's answers | top5 sentence recall | |
 |  | precision | recall |  |  |  |
Eligibility criteria | 50 | 0.78 | 0.78 | 0.98 | 133 | 0.77 |
Sample size | 50 | 0.77 | 0.68 | 0.84 | 52 | 0.83 |
Start date of enrolment | 37 | 0.97 | 0.86 | 0.86 | 37 | 0.86 |
End date of enrolment | 37 | 0.91 | 0.81 | 0.89 | 37 | 0.89 |
Name of experimental treatment | 50 | 0.86 | 0.86 | 0.98 | 56 | 0.95 |
Name of control treatment | 50 | 0.86 | 0.86 | 1.00 | 54 | 0.96 |
Dose | 49 | 0.81 | 0.78 | 0.98 | 72 | 0.90 |
Frequency of treatment | 41 | 0.80 | 0.78 | 1.00 | 55 | 0.95 |
Route of treatment | 37 | 0.86 | 0.81 | 0.95 | 39 | 0.95 |
Duration of treatment | 41 | 0.74 | 0.76 | 0.93 | 44 | 0.91 |
Primary outcome name | 48 | 0.66 | 0.69 | 0.88 | 52 | 0.81 |
Primary outcome time point | 31 | 0.53 | 0.61 | 0.81 | 33 | 0.76 |
Secondary outcome name | 43 | 0.69 | 0.79 | 0.98 | 49 | 0.88 |
Secondary outcome time point | 26 | 0.69 | 0.69 | 0.88 | 29 | 0.83 |
Funding organization name | 40 | 0.47 | 0.50 | 0.72 | 42 | 0.74 |
Funding number | 5 | 0.31 | 0.80 | 0.80 | 5 | 0.80 |
Early stopping | 2 | 0.33 | 1.00 | 1.00 | 2 | 1.00 |
Registration identifier of trial | 31 | 1.00 | 0.94 | 0.94 | 31 | 0.94 |
Author name | 50 | 0.98 | 0.98 | 0.98 | 50 | 0.98 |
Date of publication | 50 | 0.98 | 0.98 | 0.98 | 50 | 0.98 |
DOI | 48 | 1.00 | 0.98 | 0.98 | 48 | 0.98 |
Micro-average | 816 | 0.80 | 0.80 | 0.93 | 970 | 0.88 |
Macro-average | Â | 0.76 | 0.81 | 0.92 | Â | 0.89 |